Rinvoq
NDC 0074-2310 · AbbVie Inc.
Generic nameUpadacitinib
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)UPADACITINIB
Strength30 mg/1
Pharmacologic classJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
Marketing categoryNDA
Packages
0074-2310-20 — 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-20)
0074-2310-30 — 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-30)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0074-1043 — Upadacitinib, 0074-2306 — Upadacitinib, 0074-2320 — Upadacitinib